Clinical Research at Sunway Medical Centre Penang

Advancing medicine, improving lives.

At Sunway Medical Centre Penang, our clinical trials provide patients with the opportunity to access innovative treatments while helping to shape the future of healthcare. By participating, you play a vital role in discovering safer, more effective ways to prevent, detect, and treat diseases.

What Are Clinical Trials?

Clinical trials are carefully designed research studies that test new medical strategies, drugs, or devices. They help doctors and scientists to determine whether new treatments are safe and effective. These studies are essential in developing better healthcare solutions for patients worldwide and play a crucial role in advancing medical knowledge, improving treatments, and shaping the future of medicine for generations to come.

Why Participate in a Clinical Trial?

Joining a clinical trial means you are contributing to medical progress while receiving expert care. Some of the key benefits include:

Why Participate in a Clinical Trial Table?

Active Clinical Trials

Explore our current list of active clinical trials. Each study is designed to evaluate new and promising treatment options, especially for patients with advanced cancers. If you meet the eligibility criteria, you may qualify to participate.

No.	Protocol title	Therapeutic Area	Criterias	Participating Doctor	Study Status
1.	Locally advanced or metastatic non-small cell lung cancer (NSCLC) with HER2-activating mutations.	Oncology	NSCLC Her2-activating mutation Age 18 and above Able to comply with study procedures Never received any previous cancer therapy	Dr Cheah Soon Keat (PI) Dr Ho Kean Fatt (Sub-I)	Recruiting
2.	EGFR-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer	Oncology	NSCLC EGFR mutation Age 18 and above Able to comply with study procedures Osimertinib Therapy given after the initial or first-line treatment has stopped working	Dr Cheah Soon Keat (PI) Dr Ho Kean Fatt (Sub-I) Dr Doris Chow Sze Ying (Sub-I)	Recruiting
3.	PD-L1 negative and PD-L1 low Squamous (SQ) and Non-Squamous (NSQ) Non-small Cell Lung Cancer with Solid Tumors	Oncology	PD-L1 Negative or PD-L1 Low test results Age 18 and above Able to comply to study procedures Never received any previous cancer therapy	Dr Ho Kean Fatt (PI) Dr Cheah Soon Keat (Sub-I) Dr Doris Chow Sze Ying (Sub-I)	Recruiting
4.	PD-L1-high Metastatic Non-small Cell Lung Cancer	Oncology	mNSQ-NSCLC PD-L1 High test results Age 18 and above Able to comply to study procedures Have not received systemic therapy in metastatic setting	Dr Ho Kean Fatt (PI) Dr Cheah Soon Keat (Sub-I) Dr Doris Chow Sze Ying (Sub-I)	Coming soon
5.	Acute myocardial infarction in patient with a recent history of acute myocardial infarction (AMI)	Cardiology	Confirmed diagnosis of symptomatic type 1 AMI Age 18 and above Able to comply to study procedures and follow-up Willing to use self-administered autoinjector	Dr Khaw Chee Sin (PI) Dr Tan Nee Hooi (Sub-I) Dr Zubin Othman (Sub-I)	Coming soon